Skip to main content
Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · IEX Real-Time Price · USD
37.07
-0.18 (-0.48%)
May 2, 2024, 4:00 PM EDT - Market closed

Astrana Health Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Astrana Health stock has a target of 44, which predicts an increase of 18.69% from the current stock price of 37.07.

Analyst Consensus: Hold
Target Low Average Median High
Price $44 $44 $44 $44
Change +18.69% +18.69% +18.69% +18.69%
* Price targets were last updated on Mar 1, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Astrana Health is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Mar '24Apr '24
Strong Buy 00
Buy 00
Hold 11
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jailendra Singh
Truist Securities
 Truist Securities
Hold
Maintains
$41 → $44
 Hold Maintains $41 → $44 +18.69% Mar 1, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.80B
from 1.39B
Increased by 29.66%
Revenue Next Year
2.16B
from 1.80B
Increased by 20.30%
EPS This Year
1.54
from 1.29
Increased by 19.40%
EPS Next Year
1.76
from 1.54
Increased by 14.07%
Year 20192020202120222023202420252026
Revenue
560.62M687.18M773.92M1.14B1.39B1.80B2.16B2.27B
Revenue Growth
7.83%22.58%12.62%47.84%21.19%29.66%20.30%5.04%
EPS
0.391.011.520.991.291.541.762.22
EPS Growth
34.48%158.97%50.50%-34.87%30.30%19.40%14.07%26.56%
No. Analysts -----973
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 1.9B 2.5B 2.3B
Avg 1.8B 2.2B 2.3B
Low 1.6B 2.0B 2.2B

Revenue Growth

Revenue Growth 202420252026
High
39.0%
37.2%
8.1%
Avg
29.7%
20.3%
5.0%
Low
18.6%
10.3%
0.9%

EPS Forecast

EPS 202420252026
High 1.80 1.96 2.29
Avg 1.54 1.76 2.22
Low 1.35 1.50 2.14

EPS Growth

EPS Growth 202420252026
High
39.2%
27.5%
30.3%
Avg
19.4%
14.1%
26.6%
Low
4.8%
-2.6%
21.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.